AstraZeneca boss: Pfizer bid 'will disrupt shareholders'
AstraZeneca's chief executive has said that Pfizer's proposed bid to takeover the company will be a "disruption" for staff and shareholders.
Pascal Soriot faced questioning by MPs and interested parties about the likely effect of what could be the biggest takeover of a UK company.
13 May 2014
- From the section Business